Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment

Valvular heart disease (VHD) is encountered in approximately 1% of pregnancies, significantly increasing both maternal and foetal risk. Rheumatic VHD remains the most common form in non-Western countries, whereas congenital heart disease dominates in the Western world. The risk of complications vari...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chiara Fraccaro, Noemie Tence, Giulia Masiero, Nicole Karam
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/a902c31fc5904d3d8d06c2698a2c2659
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a902c31fc5904d3d8d06c2698a2c2659
record_format	dspace
spelling	oai:doaj.org-article:a902c31fc5904d3d8d06c2698a2c26592021-12-04T16:03:21ZManagement of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment10.15420/icr.2020.061756-14851756-1477https://doaj.org/article/a902c31fc5904d3d8d06c2698a2c26592020-07-01T00:00:00Zhttps://www.icrjournal.com/articleindex/icr.2020.06https://doaj.org/toc/1756-1477https://doaj.org/toc/1756-1485Valvular heart disease (VHD) is encountered in approximately 1% of pregnancies, significantly increasing both maternal and foetal risk. Rheumatic VHD remains the most common form in non-Western countries, whereas congenital heart disease dominates in the Western world. The risk of complications varies according to the type and severity of the underlying VHD. Moreover, pregnancy is a hypercoagulable state associated with increased risk of thromboembolism. The authors review the main VHDs encountered during pregnancy, and suggest management strategies based on the 2018 European Society of Cardiology recommendations for the management of pregnant women with VHD, providing an overview of classical and new transcatheter structural therapeutic options with a special focus on radiation exposure and anticoagulation drug management.Chiara FraccaroNoemie TenceGiulia MasieroNicole KaramRadcliffe Medical MediaarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENInterventional Cardiology: Reviews, Research, Resources, Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Chiara Fraccaro Noemie Tence Giulia Masiero Nicole Karam Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
description	Valvular heart disease (VHD) is encountered in approximately 1% of pregnancies, significantly increasing both maternal and foetal risk. Rheumatic VHD remains the most common form in non-Western countries, whereas congenital heart disease dominates in the Western world. The risk of complications varies according to the type and severity of the underlying VHD. Moreover, pregnancy is a hypercoagulable state associated with increased risk of thromboembolism. The authors review the main VHDs encountered during pregnancy, and suggest management strategies based on the 2018 European Society of Cardiology recommendations for the management of pregnant women with VHD, providing an overview of classical and new transcatheter structural therapeutic options with a special focus on radiation exposure and anticoagulation drug management.
format	article
author	Chiara Fraccaro Noemie Tence Giulia Masiero Nicole Karam
author_facet	Chiara Fraccaro Noemie Tence Giulia Masiero Nicole Karam
author_sort	Chiara Fraccaro
title	Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
title_short	Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
title_full	Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
title_fullStr	Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
title_full_unstemmed	Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
title_sort	management of valvular disease during pregnancy: evolving role of percutaneous treatment
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/a902c31fc5904d3d8d06c2698a2c2659
work_keys_str_mv	AT chiarafraccaro managementofvalvulardiseaseduringpregnancyevolvingroleofpercutaneoustreatment AT noemietence managementofvalvulardiseaseduringpregnancyevolvingroleofpercutaneoustreatment AT giuliamasiero managementofvalvulardiseaseduringpregnancyevolvingroleofpercutaneoustreatment AT nicolekaram managementofvalvulardiseaseduringpregnancyevolvingroleofpercutaneoustreatment
_version_	1718372753552179200

Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment

Ejemplares similares